Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tali Cukierman-Yaffe MD, MSC

Tali Cukierman-Yaffe MD, MSC

Head, Endocrinology & Diabetes Service for Women and in Pregnancy, Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center; Epidemiology Department, Sackler Faculty of Medicine, Herczeg Institute on Aging, Tel Aviv University, Tel Aviv, Israel

Prof. Tali Cukierman-Yaffe is an endocrinologist and a clinical epidemiologist. A senior physician in the Endocrinology Institute, the head of the Centre for Successful Aging with Diabetes at the Sheba Medical Centre, head of the Endocrinology & Diabetes service for women &n pregnancy an associate professor at the Epidemiology department at Tel-Aviv University and a member of the Herczeg institute on aging. She is also a PHRI (Population Health Research Institute, Mcmaster University, Canada) senior international fellow.

The focus of her research is the relationship between diabetes and cognitive dysfunction and the challenges of treating diabetes in older age. She has published many articles and has given numerous talks on this topic, is part of working groups writing local and international guidelines on this topic and is an invited advisor in forums dealing with this subject. Thus, she was PI of the cognitive sub-study of the ORIGIN trial, a co-investigator of the ACCORD-MIND study and took a key role in the cognitive sub-study of the REWIND trial that tested the cognitive safety and efficacy of Dulaglutide in people with diabetes.

In the last several years, her research has also been focused on finding technological solutions to improve the care of older people with diabetes. Thus, she is the Principal investigator of a EFSD funded study aimed at developing a technological solution for the replacement of traditional physical capacity assessments for older people with diabetes and another study aimed at developing a digital Digit Substitution Test (DSS) cognitive assessment tool.